Kalorama Announces New Report on Clinical Laboratory Services Market
| PR Web |
Kalorama Information announces the publication of a new research study on the market for clinical lab services: “Clinical Laboratory Services (Markets, Growth Opportunities, Competitive Analysis and Competitor Profiles),” http://www.kaloramainformation.com/Clinical-Lab-Services-7931450/.
The market for clinical lab services is dynamic. It is estimated that approximately 80% of physician's diagnoses are a result of laboratory tests, and a fair number of these tests are sent to clinical lab service providers. There is constant pressure to reduce healthcare spending, and that in turn is shifting healthcare utilization in favor of the laboratory. This has not escaped the attention of major competitors who operate in the industry, and those planning to enter. “Clinical Laboratory Services (Markets, Growth Opportunities, Competitive Analysis and Competitor Profiles),” provides an in-depth market overview, a total market analysis, analysis by laboratory type, and by routine and specialty testing and a review of the latest trends driving growth. Revenues and forecasts, segment breakouts and market share presented are for the U.S. market, but international clinical lab service markets are estimated and forecasted in this report. Key market data provided includes:
• Hospital, Physician and Independent Lab Statistics
• Major Tests Performed by Clinical Lab Companies
• Disease Incidence and Trends Driving Lab Business
• Market Forecast to 2018
• Geographic Breakout of Clinical Lab Services Market (includes US, Europe Asia with specific breakouts for
• Market Breakdown by Lab Type (Hospital, Physician, Independent)
• Market Breakdown by Test Type (Specialty, Routine)
• US Market Share of Competitors
• Competitive Analysis of Leading clinical Lab Providers
A trend towards preventive and risk factor testing has been noted in several disciplines, particularly in the areas of oncology, endocrinology, and gynecology. Physicians in these areas are taking full advantage of testing for early detection and disease prevention. Some of the other issues and trends explored in this study include:
• U.S. Demographics
• Types of Specialty Tests
• Growing Competition
• Increasing Life Expectancy
• Growing Incidence of Disease
• New Product Offerings
• Regulatory Environment
• Insurance and Reimbursement
• Payer Types
• Developments in Personalized Medicine
A competitive analysis of leading clinical laboratory providers includes:
• Quest Diagnostics, Inc.
• Laboratory Corporation of America (
• Genomic Health
• Genoptix, Inc.
• Genzyme Corporation
• DaVita
• Clarient, Inc.
• Spectra Laboratories
• Bio-Reference Laboratories
The information in this report is the result of interviews with executives and market experts, as well as thorough research of secondary sources such as company literature, trade publications and medical and business journals. The emphasis Kalorama puts on primary research guarantees that new insights will be uncovered that are not available from any other source. The most important part of Kalorama's efforts is its superior analysis of company activities and their true significance in the marketplace. Historical data was provided for the years 2008- 2012, with forecast data provided for 2013 through 2017. A competitive analysis is provided for the year 2013. The forecasted market analysis for 2013-2017 was largely based on demographic trends, new developments, company performance trends, mergers and acquisitions, and national expansion.
Information on this report can be found at Kalorama Information’s website at: http://www.kaloramainformation.com/Clinical-Lab-Services-7931450/.
About Kalorama Information
Kalorama Information, a division of
Read the full story at http://www.prweb.com/releases/2014/01/prweb11474474.htm
| Copyright: | (c) 2014 PRWEB.COM Newswire |
| Wordcount: | 565 |



Clio Awards Announce Clio Sports, Honoring Excellence In Sports Marketing And Advertising
blinkx plc Appoints Judy Vezmar To Board of Directors
Advisor News
- Advisors must lead the policy risk conversation
- Gen X more anxious than baby boomers about retirement
- Taxing trend: How the OBBBA is breaking the standard deduction reliance
- 6 in 10 Americans struggle with financial decisions
- New Trump administration rule seeks to bail out private equity, credit with workers’ 401(k) savings
More Advisor NewsAnnuity News
- ‘I get confused:’ Regulators ponder increasing illustration complexities
- Three ways the Corebridge/Equitable merger could shake up the annuity market
- Corebridge, Equitable merge to create potential new annuity sales king
- LIMRA: Final retail annuity sales total $464.1 billion in 2025
- How annuities can enhance retirement income for post-pension clients
More Annuity NewsHealth/Employee Benefits News
- Garson to run for NC Senate District 23 seat
- New York lawmakers introduce bills aimed at maintaining vaccine access, updating state oversight
- DESPITE POSTPARTUM MEDICAID COVERAGE GAINS FOR BLACK WOMEN, SIGNIFICANT EQUITY GAPS PERSIST
- LEVERAGING EXISTING INFRASTRUCTURE AND PARTNERSHIPS TO IMPROVE CHILD HEALTH OUTCOMES
- Congress, end the "prior authorization" health-care scam
More Health/Employee Benefits NewsLife Insurance News
- From marathons to mountaineering: Ranking which sports and hobbies affect life insurance the most
- AMERICA'S CREDIT UNIONS HIRES VETERAN WASHINGTON ADVOCATE TO LEAD POLICY STRATEGY
- Society of Actuaries announces Clar Rosso as next CEO
- AM Best Affirms Credit Ratings of Fidelity & Guaranty Life Holdings, Inc. and Its Life/Health Subsidiaries
- Hawai'i's Top Employers Profiles 2026
More Life Insurance News